AMERICAN BATTERY TECHNOLOGY Co financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AMERICAN BATTERY TECHNOLOGY Co files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
0
0
0
0.34
4.29
21.7
Cost of revenue
3.3
14.9
24.8
Gross profit
-2.96
-10.6
-3.09
Research and development
0.86
0.96
7.57
14.3
8.47
17.9
Selling and marketing
0
0
General and administrative
1.09
5.21
9.45
36.3
31.7
12.8
16.1
21.2
51.6
Operating expenses
37.7
33.7
22.4
44.8
31.4
71.6
Operating income
-2.4
-5.59
-10.5
-37.7
-33.7
-22.4
-47.8
-42
-74.7
Interest expense
0.04
0.29
2.49
0.13
0
0
0
Other non-operating income
-26
-0.46
-2.14
-4.04
0.2
0.24
-4.73
-4.74
1.33
Pre-tax income
-28.3
-46.8
-73.4
Income tax
0
Net income
-28.4
-2.69
-6.05
-12.6
-41.8
-33.5
-21.3
-52.5
-46.8
-73.4
EBITDA
-37.7
-33.7
-22.3
-46.1
-37
-69.7
EPS, basic
-0.69
-0.07
-0.11
-0.08
-0.83
-0.51
-1.02
-0.58
-0.58
EPS, diluted
-0.69
-0.07
-0.11
-0.08
-0.83
-0.51
-1.02
-0.58
-0.58
Shares, basic (weighted)
41.5
79.1
109
479
40.1
43.8
51.2
80.3
128
Shares, diluted (weighted)
41.5
79.1
109
479
40.1
43.8
51.2
80.3
128
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
0.09
0.01
0.12
0.01
12.8
29
2.32
7
7.47
49.5
Receivables
0.23
2.8
6.95
Inventory
0.13
0.15
0.41
0.58
Other current assets
0
0.05
0.19
0.05
1.29
0.88
1.81
2.88
0.56
Total current assets
0.09
0.06
0.31
0.06
14.1
29.9
4.75
18.4
29.5
60.9
Property, plant and equipment
0
5.48
18.9
29.9
46.3
45.5
57.3
Lease right-of-use assets
0.24
0.14
0.04
0.3
0.17
Intangible assets
1.64
3.85
3.85
4.52
0.77
4.62
Other non-current assets
27.7
Total assets
0.09
0.06
0.31
0.09
21.3
52.9
74.7
77.7
84.5
133
Accounts payable
0.42
0.41
0.51
0.59
1.62
0.34
1.83
4.26
0.42
1.57
Accrued liabilities
1.8
Short-term debt
6.45
7.73
Total current liabilities
0.63
1.33
2.74
4.88
1.82
3.05
13.7
15.8
13.7
6.39
Long-term debt
0
0
0
0.05
Lease liabilities
0.18
0.05
0.19
0.06
Total liabilities
0.63
1.33
2.74
4.88
1.82
3.23
13.8
16.2
13.9
6.45
Total debt
7.08
7.73
Paid-in capital
27.9
29.9
34.7
45
122
188
223
276
330
460
Retained earnings
-28.5
-31.2
-37.3
-49.9
-105
-139
-161
-213
-260
-333
Shareholders' equity
-0.54
-1.27
-2.43
-4.79
19.4
49.6
60.9
61.5
70.6
126
Total equity
-0.54
-1.27
-2.43
-4.79
19.4
49.6
60.9
61.5
70.6
126
Total liabilities and equity
0.09
0.06
0.31
0.09
21.3
52.9
74.7
77.7
84.5
133
Shares outstanding
54.9
58.5
89.7
127
551
41.3
45.9
64.1
97.4
142
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
-28.4
-2.69
-6.05
-12.6
-41.8
-33.5
-21.3
-52.5
-46.8
-73.4
Depreciation and amortization
0.01
0.05
0.1
1.7
5
5
Stock-based compensation
1.23
9.76
14.6
14.7
46.5
Change in receivables
-0.23
-2.57
-4.15
Change in inventory
-0.13
-0.62
-3.17
-1.06
Change in payables
0.2
0.09
0.14
0.2
1
0.65
0.16
5.43
-2.76
0.37
Cash from operations
-0.2
-0.48
-0.99
-3.23
-7.76
-10.2
-13.4
-16.7
-28.9
-24.2
Capital expenditures
0
-0.01
0
-5.44
-12.9
-6.76
Cash from investing
0
0
-0.01
0
-7.08
-15.1
-36.7
-13
-2.55
-13.6
Debt issued
1.4
Debt repaid
-0.06
Stock issued
15.5
36.9
13.9
38.1
18.6
Dividends paid
-0.13
Cash from financing
0.28
0.4
1.12
3.12
26.9
41.4
23.4
34.4
36.9
75.6
Net change in cash
0.08
-0.08
0.11
-0.12
12
16.1
-26.7
4.68
5.47
37.8
Free cash flow
-0.2
-1
-3.23
-13.2
-23.1
-20.1
Interest paid
0
0
0
0
0.06
0.13
0.03
0.02
0.03
Income taxes paid
0
0
0
0
1.29
Key metrics
Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $2.26 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
-14.2%
Gross profit / revenue.
Operating margin
-343.6%
Operating income / revenue.
EBITDA margin
-320.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-337.5%
Pre-tax income / revenue.
Net margin
-337.5%
Net income / revenue.
Operating cash flow margin
-111.2%
Cash from operations / revenue.
Return on equity (ROE)
-74.5%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-67.5%
Net income / average total assets.
Return on invested capital (ROIC)
-79.9%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
82.2%
Research and development expense / revenue.
Stock-based pay / revenue
213.8%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
23.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
406.8%
Revenue vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
79.0%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
27.6%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
45.4%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
57.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
21.2%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
44.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
58.8%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
42.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-23.2%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
9.53x
Current assets / current liabilities.
Quick ratio
8.83x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
7.74x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.58
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.58
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.17
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.19
Cash from operations / diluted weighted shares.
Book value per share
$0.89
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
14.2x
Market cap / revenue.
P/B
2.44x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
2.53x
Market cap / tangible book value, when positive.
EV/Sales
11.9x
Enterprise value / revenue.
Earnings yield
-23.8%
Net income / market cap (the inverse of P/E).
What was AMERICAN BATTERY TECHNOLOGY Co's revenue in fiscal 2026?
AMERICAN BATTERY TECHNOLOGY Co reported revenue of $21.7M for fiscal 2026, 406.8% higher than the year before.
Was AMERICAN BATTERY TECHNOLOGY Co profitable in fiscal 2026?
No. It reported a net loss of $73.4M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.